BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will participate on a panel at BioFlorida's 10th annual conference titled "Raising Capital" on October 17 in Weston, FL.
News | 10. 17. 2007
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.